radium-224

Open Access
Estimating the Risk for Secondary Cancer After Targeted α-Therapy with ²¹¹At Intraperitoneal Radioimmunotherapy
Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm and Per Albertsson

Journal of Nuclear Medicine January 1, 2023, 64 (1) 165-172; DOI: https://doi.org/10.2967/jnumed.121.263349